Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Wressnigg, Nina; Poellabauer, Eva-Maria; Aichinger, Gerald; Portsmouth, Daniel; Loew-Baselli, Alexandra; Fritsch, Sandor; Livey, Ian; Crowe, Brian A.; Schwendinger, Michael; Bruehl, Peter; Pilz, Andreas; Dvorak, Thomas; Singer, Jiulia; Firth, Clair; Luft, Benjamin; Schmitt, Bernhard; Zeitlinger, Markus; Mueller, Markus; Kollaritsch, Herwig; Paulke-Korinek, Maria; Esen, Meral; Kremsner, Peter G.; Ehrlich, Hartmut J.; Barrett, P. Noel

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Autor(en):

Wressnigg, Nina; Poellabauer, Eva-Maria; Aichinger, Gerald; Portsmouth, Daniel; Loew-Baselli, Alexandra; Fritsch, Sandor; Livey, Ian; Crowe, Brian A.; Schwendinger, Michael; Bruehl, Peter; Pilz, Andreas; Dvorak, Thomas; Singer, Jiulia; Firth, Clair; Luft, Benjamin; Schmitt, Bernhard; Zeitlinger, Markus; Mueller, Markus; Kollaritsch, Herwig; Paulke-Korinek, Maria; Esen, Meral; Kremsner, Peter G.; Ehrlich, Hartmut J.; Barrett, P. Noel

Tübinger Autor(en):

Esen, Meral
Kremsner, Peter

Erschienen in:

Lancet Infectious Diseases (2013), Bd. 13, H. 8, S. 680-689

Verlagsangabe:

Elsevier Science Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S1473-3099(13)70110-5

ISSN:

1473-3099